RELMADA THERAPEUTICS, INC. (RLMD)
Data as of , from SEC Form 4 filings.
Net insider buying (90d)Watch RLMD
See up to 3 months of RLMD. The 7-day demo opens the 1M and 3M ranges and puts RLMD on your watchlist.
Start 7-day demoLatest RLMD insider trades
Maged Shenouda - OfficerOpen-market purchase$505K- Maged Shenouda
About RELMADA THERAPEUTICS, INC. (RLMD)
The SEC lists RELMADA THERAPEUTICS, INC. under CIK 0001553643, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
RLMD Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 4 | 400,000 | $1.67M |
RLMD insider transactions (Form 4)
2216 Form 4 filings on record, the earliest from Oct 23, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Maged Shenouda - Officer | Open-market purchase | Common Stock | 120,200 footnote F1 | $4.20 footnote F2 | $505K | |
| Maged Shenouda - Officer | Open-market purchase | Common Stock | 79,800 | $4.25 | $339K | |
| ||||||
| Sergio Traversa - Officer | Open-market purchase | Common Stock | 100,000 footnote F1 | $4.18 footnote F2 | $418K | |
| Sergio Traversa - Officer | Open-market purchase | Common Stock | 100,000 footnote F1 | $4.10 footnote F3 | $410K | |
| ||||||
| Sergio Traversa - Officer | Open-market purchase | Common Stock | 27,500 footnote F1 | $4.12 footnote F2 | $113K | |
| Sergio Traversa - Officer | Grant or award | Stock Appreciation Rights | 1,198,000 | $0.00 | - | |
| ||||||
| Maged Shenouda - Officer | Open-market purchase | Common Stock | 11,665 | $4.12 | $48K | |
| Maged Shenouda - Officer | Grant or award | Stock Appreciation Rights | 828,000 | $0.00 | - | |
| Chuck Ence - Officer | Grant or award | Stock Appreciation Rights | 828,000 | $0.00 | - | |
| Fabiana Fedeli - Director | Grant or award | Stock Appreciation Rights | 164,000 | $0.00 | - | |
| John Glasspool - Director | Grant or award | Stock Appreciation Rights | 164,000 | $0.00 | - | |
| Paul Edward Kelly - Officer | Grant or award | Stock Appreciation Rights | 828,000 | $0.00 | - | |
| Charles J. Casamento - Director | Grant or award | Stock Appreciation Rights | 164,000 | $0.00 | - | |
| Chuck Ence - Officer | Open-market purchase | Common Stock | 136,000 | $2.20 | $299K | |
| Sergio Traversa - Officer | Open-market purchase | Common Stock | 272,500 | $2.20 | $600K | |
| Maged Shenouda - Officer | Open-market purchase | Common Stock | 500,000 | $2.20 | $1.10M | |
| Paul Edward Kelly - Officer | Open-market purchase | Common Stock | 90,000 | $2.20 | $198K | |
| Sergio Traversa - Officer | Open-market purchase | Common Stock | 80,545 | $0.62 | $50K | |
| Sergio Traversa - Officer | Open-market purchase | Common Stock | 129,455 | $0.67 | $87K | |
| Sergio Traversa - Officer | Open-market purchase | Common Stock | 55,976 | $0.74 | $41K | |
| Charles J. Casamento - Director | Grant or award | Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Charles J. Casamento - Director | Gift | Common Stock | 13,000 | $0.00 | - | |
Item 8.01
Item 2.02, 7.01, 9.01
Item 7.01, 9.01
Item 5.03, 5.07, 9.01
RLMD insider trading FAQ
What is the latest insider trade for RLMD?
RELMADA THERAPEUTICS, INC. (RLMD) had 2 insider filings in the last 90 days, with the most recent on 11 September 2026. The full record for RLMD runs to 16 Form 4 filings, the earliest from 23 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying RLMD stock?
4 insider purchases of RLMD were filed in the last 90 days, totaling $1.67M.
How many insiders are selling RLMD stock?
No insider sales of RLMD were filed in the last 90 days.
Where can I see RLMD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects RLMD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Maged Shenouda view on EDGAR
- - Sergio Traversa view on EDGAR
- - Sergio Traversa view on EDGAR
- - Maged Shenouda view on EDGAR
- - Chuck Ence view on EDGAR
- - Fabiana Fedeli view on EDGAR
- - John Glasspool view on EDGAR
- - Paul Edward Kelly view on EDGAR
- - Charles J. Casamento view on EDGAR
- - Chuck Ence
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where RLMD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow RLMD with a 7-day demo
- RLMD on your watchlist
- Every RLMD Form 4 filing on record
- Up to 3 months of RLMD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
